News | PET-MRI | October 10, 2018

Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.

Scanner will allow HCI to perform higher throughput screening of rodent tumor models, improve testing of novel cancer therapies

Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.

October 10, 2018 — The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake City has become the first site in the U.S. to install the nanoScan PET/MRI 3T preclinical in vivo imaging system. This is the 10th installation of the nanoScan positron emission tomography/magnetic resonance imaging (PET/MRI) 3T worldwide.

In 2015, HCI became the Center of Excellence for Preclinical Imaging by Mediso Ltd. and its affiliate company Mediso USA with the installation of four modalities, the nanoScan PET/MRI 1T and nanoScan single photon emission computed tomography (SPECT)/computed tomography (CT) to advance its cancer imaging techniques. Three years later, HCI is now upgrading their current system with the 3 Tesla superconducting cryogen-free magnet to support the opening of a dedicated vivarium and preclinical imaging laboratory in the new Primary Children's and Families' Cancer Research Center.  Through a clinical 3T magnetic field, the system allows the translational in vivo imaging of small animals and is particularly suitable for examinations requiring greater sensitivity, including brain imaging.

"The installation of the 3 Tesla PET/MRI will allow us to perform higher throughput screening of a wide range of rodent tumor models as well as improve our testing of novel cancer therapies with better image quality," said Jeffrey Yap, Ph.D., co-director, Center for Quantitative Cancer Imaging, Huntsman Cancer Institute.

For more information: www.medisousa.com

Related Content

New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...